This is consistent with a report by Charlton M et al. [30], which revealed that FABP1 levels are also reduced in advanced nonalcoholic steatohepatitis and may cause lipotoxicity in hepatic fat accumulation. Here, FABP1 is linked to metabolic dysfunction-associated steatohepatitis.